Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer’s Disease

Figure 4

The concentrations of the 4 identified serum miRNAs in mild cognitive impairment (MCI) cases, vascular dementia (VD), and all nondementia controls (NC) enrolled in the study. The absolute concentrations of 4 identified serum miRNAs in 30 MCI, 30 VD, and 123 NC patients using a RT-qPCR assay (a–d). The absolute concentrations of the miRNAs were calculated based on the standard curves. Each value was derived using a nonparametric Mann-Whitney -test. .

(a)

(b)

(c)

(d)